Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00195156 · ClinicalTrials.gov registry record · Phase 1
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 1
- Development phase
NCT00195156 is a Phase 1 study that was terminated before completion, run by Weill Medical College of Cornell University.
The verdict
NCT00195156, a Phase 1 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to find out the highest tolerated dose of Depakote in combination with liposome encapsulated all-trans retinoic acid (ATRA-IV) in patients with advanced solid tumor malignancies.
Interventions
- DRUG ATRA-IV
- DRUG Depakote
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00195156
The ClinicalTrials.gov registry entry for NCT00195156 describes a study currently listed as terminated, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ATRA-IV is the first listed.
NCT00195156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00195156 about?
NCT00195156 is a clinical study titled "Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies". The purpose of this study is to find out the highest tolerated dose of Depakote in combination with liposome encapsulated all-trans retinoic acid (ATRA-IV) in patients with advanced solid tumor malignancies.
What is the current status of trial NCT00195156?
This trial is currently terminated. It is a Phase 1 study. The study started on 2003-07.
What interventions are being tested in trial NCT00195156?
The interventions under investigation include: ATRA-IV (DRUG), Depakote (DRUG).
Who is sponsoring clinical trial NCT00195156?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.